SCHEMBL7833447

SCHEMBL7833447

Clc1ccc(Cn2[c]nc3cccnc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXA2R P21731 1/20 0.44
ALDH1A1 P00352 2/20 0.42
TP53 P04637 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KDM4E B2RXH2 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPK1 P28482 2/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.40
EP300 Q09472 1/20 0.40
CREBBP Q92793 1/20 0.40
KAT2A Q92830 1/20 0.40
KAT2B Q92831 1/20 0.40
ENPP2 Q13822 1/20 0.39
PABPC1 P11940 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7832090 0.87 L3MBTL1 (0.44) TP53KDM4EL3MBTL1CYP11B1CYP11B2
SCHEMBL9695569 0.86 TP53 (0.44) TP53KDM4EMEN1KMT2AKAT2B
SCHEMBL7834654 0.85 HTT (0.49) ALDH1A1KDM4EL3MBTL1CYP11B1CYP11B2
SCHEMBL7835831 0.85 CYP11B1 (0.46) TBXA2RALDH1A1TP53KDM4EL3MBTL1
SCHEMBL7835667 0.78 MAPT (0.43) ALDH1A1TP53KDM4EL3MBTL1EP300
SCHEMBL944723 0.78 TDP1 (0.51) TBXA2RALDH1A1TP53NPSR1MAPK1
SCHEMBL7833661 0.77 PDE10A (0.37) TBXA2RALDH1A1TP53L3MBTL1SMN1; SMN2
SCHEMBL13508712 0.73 TP53 (0.68) TBXA2RALDH1A1TP53NPSR1KDM4E
SCHEMBL15654857 0.72 TP53 (0.33) ALDH1A1TP53NPSR1KDM4EMEN1
SCHEMBL9701321 0.70 TBXA2R (0.53) TBXA2RTP53NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed